Fructose-4-epimerase and method for preparing tagatose using same

US12460236B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12460236-B2
Application numberUS-202017635157-A
CountryUS
Kind codeB2
Filing dateAug 13, 2020
Priority dateAug 14, 2019
Publication dateNov 4, 2025
Grant dateNov 4, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application relates to a fructose-4-epimerase variant exhibiting tagatose conversion activity and a method for preparing tagatose using the same.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A fructose-4-epimerase variant, comprising substitutions of amino acid residues corresponding to positions 97, 124, 367, and 390 from a N-terminus of a fructose-4-epimerase comprising the amino acid sequence of SEQ ID NO: 1 with other amino acids. 2 . The fructose-4-epimerase variant according to claim 1 , wherein the other amino acids are selected from the group consisting of a non-polar amino acid, a polar amino acid, and a basic amino acid. 3 . The fructose-4-epimerase variant according to claim 2 , wherein the non-polar amino acid, polar amino acid, and basic amino acid are selected from the group consisting of tyrosine (Y), tryptophan (W), valine (V), and arginine (R). 4 . The fructose-4-epimerase variant according to claim 1 , wherein the variant further comprises a substitution of an amino acid corresponding to position 158 or 321 with another amino acid. 5 . The fructose-4-epimerase variant according to claim 4 , wherein the another amino acid is selected from the group consisting of glutamine (Q), histidine (H), alanine (A), valine (V), glycine (G), threonine (T), glutamic acid (E), methionine (M), arginine (R), leucine (L), asparagine (N), isoleucine (I), and lysine (K). 6 . The fructose-4-epimerase variant according to claim 1 , wherein the variant further comprises a substitution of amino acid residues corresponding to one or more positions selected from the group consisting of position 210, position 239, and position 318 with other amino acids. 7 . A polynucleotide encoding the fructose-4-epimerase variant according to claim 1 . 8 . A vector comprising the polynucleotide according to claim 7 . 9 . A microorganism comprising the fructose-4-epimerase variant according to claim 1 or a vector comprising a polynucleotide encoding the fructose-4-epimerase variant according to claim 1 . 10 . A composition for tagatose production, comprising the fructose-4-epimerase variant according to claim 1 ; a microorganism comprising the fructose-4-epimerase variant; or a culture of the microorganism. 11 . The composition for tagatose production according to claim 10 , wherein the composition further comprises fructose. 12 . A method for preparing tagatose, the method comprising bringing the fructose-4-epimerase variant according to claim 1 ; a microorganism comprising the fructose-4-epimerase variant; or a culture of the microorganism into contact with fructose and converting fructose into tagatose.

Assignees

Inventors

Classifications

  • C12Y501/03Primary

    acting on carbohydrates and derivatives (5.1.3) · CPC title

  • produced by the action of an isomerase, e.g. fructose · CPC title

  • C12N9/90Primary

    Isomerases (5.) · CPC title

  • C12P19/02Primary

    Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12460236B2 cover?
The present application relates to a fructose-4-epimerase variant exhibiting tagatose conversion activity and a method for preparing tagatose using the same.
Who is the assignee on this patent?
Cj Cheiljedang Corp
What technology area does this patent fall under?
Primary CPC classification C12Y501/03. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).